LQLY — Qly Biotech Cashflow Statement
0.000.00%
Consumer CyclicalsSpeculativeMicro Cap
Annual cashflow statement for Qly Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.001 | -0.005 | -0.029 | -0.014 |
Depreciation | ||||
Amortisation | ||||
Changes in Working Capital | — | — | 0.002 | -0.002 |
Change in Accounts Payable | ||||
Cash from Operating Activities | -0.001 | -0.004 | -0.026 | -0.014 |
Capital Expenditures | — | -0.005 | 0 | — |
Purchase of Fixed Assets | ||||
Cash from Investing Activities | — | -0.005 | 0 | — |
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.006 | 0.032 | 0.004 | 0.009 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.005 | 0.023 | -0.022 | -0.005 |